Vladimir Miloradović

Vladimir Miloradović

Auto-generated profile, based on publicly available information

Vladimir Miloradović

University of Kragujevac

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
JSJelena Boskovic Sekulic
Jelena Boskovic Sekulic
ISIgor Milorad Sekulić
Igor Milorad Sekulić
BDBoris Dzudovic
Boris Dzudovic
BSBojana Subotic
Bojana Subotic
SSSonja S Salinger
Sonja S Salinger
SOSlobodan Obradovic
Slobodan Obradovic
Background/Aim. Multidetector computed tomography pulmonary angiography (MCTPA) has emerged as the most suitable method for diagnosing acute pulmonary embolism (APE) in hemodynamically stable patients. In addition to its diagnostic role, MCTPA facilitates the measurement and calculation of certain parameters that can be used as prognostic markers for outcomes in APE. Since the introduction of the method, there have been a lot of studies that pointed out there may be a significant difference in the prognostic value of MCTPA for APE concerning sex. Methods. The study population consisted of consecutive patients with a diagnosis of APE confirmed by MCTPA. Positive MCTPA findings and a diagnosis of APE were established if the patient had at least one segmental artery thrombus. APE severity was estimated using the simplified Pulmonary Embolism Severity Index (sPESI). All-cause and APE-related intrahospital deaths were the coprimary outcomes of this study. Results. In total, 1,612 patients were enrolled in the study (750 men and 862 women). Women with a centrally positioned pulmonary thrombus detected on MCTPA were more likely to die from PE-related death than those without one (10.4% vs. 4.2%, respectively; p = 0.016). Women with a right ventricle (RV) and left ventricle (LV) diameter ratio (RV/LV) > 1 died almost twice as often as those with a ratio ? 1 (15.5% vs. 8.6%, respectively; p = 0.017). Women with an RV/LV > 1 detected with MCTPA were significantly more likely to die from PE than those with a ratio ? 1 (11% vs. 5.2%, respectively; p = 0.017). Women who died from PE-related causes had a significantly higher value of the embolic burden score system (EBSS) than did the surviving women (18.00 vs. 11.00, respectively; p = 0.025). Independently of age, sPESI, and renal function, the presence of a central thrombus [odds ratio (OR) 2.278, 95% confidence interval (CI): 1.050?4.944, p = 0.037] and the RV/LV ratio > 1 (OR 2.015, 95% CI: 1.042?3.893, p = 0.037) were associated with intrahospital PE-related death in women. Conclusion. In women, MCTPA parameters, a centrally placed thrombus, the RV/LV ratio, and the EBSS had prognostic significance for PE-related mortality. The RV/LV ratio had prognostic significance for all-cause intrahospital mortality. In men, the MCTPA parameters had no prognostic significance for both overall and PE-related mortality.

1 December 2024 in AFMN Biomedicine
Verified
Journal Article
Open access
PDF file
AKAleksandra Kozić
Aleksandra Kozić
SSSonja S Salinger
Sonja S Salinger
ZDZorica Dimitrijevic
Zorica Dimitrijevic
DSDragana M. Stanojevic
Dragana M. Stanojevic
TKTomislav Kostić
Tomislav Kostić
SOSlobodan Obradovic
Slobodan Obradovic
Patients classified as belonging to simplified pulmonary embolism severity index (sPESI) class 0 are considered to have low-risk pulmonary embolism (PE). Yet, certain laboratory and echocardiographic parameters not accounted for in the sPESI score might suggest a likelihood of worse outcomes in PE cases. This study seeks to determine if the prognostic value of the sPESI score in acute PE can be improved, refined, and optimised by incorporating brain natriuretic peptide (BNP) and troponin I (TnI) levels, echocardiographic parameters, or glomerular filtration rate. The study encompassed 1,201 consecutive patients diagnosed with PE, confirmed by multidetector computed tomography (MDCT). Upon admission, each patient underwent an echocardiography exam, and blood samples were taken to measure B-type natriuretic peptide (BNP), troponin I (TnI), creatinine, and other routine laboratory markers. The in-hospital mortality rate was 11.5%. The patients were categorized into three groups using the three-level sPESI model: sPESI 0, sPESI 1, and sPESI ≥ 2. Statistically significant differences were found among these groups regarding mortality rates, TnI values, BNP levels, estimated glomerular filtration rate (eGFR), and the presence of right ventricular dysfunction (RVD). Cox regression analysis identified eGFR as the most reliable predictor of 30-day all-cause mortality [HR 2.24 (CI 1.264-3.969); p = 0.006] across all sPESI categories. However, incorporating TnI, BNP, or RVD did not improve risk prediction beyond the three-level sPESI model. Renal dysfunction at the time of admission is closely related to an elevated risk of in-hospital mortality in patients with acute PE. The three-level sPESI score offers a more accurate method for prognostic stratification in these patients.

1 January 2026 in Srpski medicinski casopis Lekarske komore
Verified
Journal Article
Open access
PDF file
Petar OtaševićPetar Otašević
Petar Otašević
JVJelisaveta Vuletić
Jelisaveta Vuletić
DMDejan Munjiza
Dejan Munjiza
SASvetlana Apostolovic
Svetlana Apostolovic
AIAndrej Ilanković
Andrej Ilanković
NVNikola Vojvodić
Nikola Vojvodić
Introduction/Objective: Insomnia is a common sleep disorder that extends beyond the subjective feeling of poor sleep and represents a state of persistent physiological hyperarousal with important cardiovascular consequences. This review aimed to summarize the pathophysiological links between insomnia and cardiovascular disease and to compare the clinical implications of benzodiazepines and Z-hypnotics in the treatment of insomnia in cardiac patients. Methods: Using a descriptive-comparative approach, we analyzed review articles, meta-analyses, cohort studies, and observational studies addressing the relationship between insomnia, cardiovascular outcomes, and pharmacological treatment, with particular focus on differences between benzodiazepines and Z-hypnotics in cardiac patients. Results: The available evidence indicates that insomnia, through autonomic, neuroendocrine, inflammatory, and metabolic dysregulation, contributes to the development of hypertension, atrial fibrillation, and heart failure, with the greatest risk observed in insomnia with objectively short sleep duration. Longitudinal studies further suggest that persistent insomnia symptoms are associated with greater cardiovascular burden. In therapeutic terms, benzodiazepines in cardiac patients are associated with higher rates of adverse events, including heart failure rehospitalization, sudden cardiac arrest, and cardiovascular mortality, whereas available data on Z-hypnotics suggest a more favorable or neutral profile. Conclusion: Insomnia is a clinically important yet often overlooked cardiovascular risk factor. In cardiac patients, its recognition and treatment should be part of a comprehensive clinical approach, prioritizing non-pharmacological measures and carefully selected pharmacotherapy. When drug treatment is necessary, Z-hypnotics may be considered a more favorable alternative to benzodiazepines, with zopiclone standing out because of its pharmacological and clinical characteristics.

10 September 2026 in Therapeutic Advances in Respiratory Disease
Verified
Journal Article
Open access
Ljiljana KosLjiljana Kos
Ljiljana Kos
TKTamara Kovacevic-Preradovic
Tamara Kovacevic-Preradovic
BDBoris Dzudovic
Boris Dzudovic
SSSonja S Salinger
Sonja S Salinger
EJEma Jevtic
Ema Jevtic
SOSlobodan Obradovic
Slobodan Obradovic
Background: Risk stratification of acute pulmonary embolism (PE) is primarily based on systolic arterial pressure, right ventricular (RV) function, and cardiac troponin levels. Objectives: To investigate sex-related differences in simple RV echocardiographic parameters for predicting all-cause in-hospital mortality in acute PE. Design: Multicenter, observational, retrospective, registry-based cohort study. Methods: We analyzed data from the Regional Pulmonary Embolism Registry, including consecutive patients with acute PE confirmed by computed tomography pulmonary angiography between January 2015 and January 2026. Of 2776 patients, 2408 had at least one RV echocardiographic parameter measured at admission (RV diastolic diameter, RV systolic pressure, tricuspid annular plane systolic excursion [TAPSE], and ratio TAPSE/RV systolic pressure). Multivariable Cox regression adjusted for age, sex-specific differences, and shock at admission (systolic arterial pressure <90 mmHg), was used to identify predictors of all-cause in-hospital mortality. Sex-specific cutoffs of echocardiographic parameters with the strongest predictive value for all-cause mortality were determined using a decision tree. Results: All-cause in-hospital mortality rates were similar between men (7.6%, 83/1125) and women (9.2%, 118/1283; p=0.107). TAPSE was the only echocardiographic parameter independently associated with all-cause in-hospital mortality in women (adjusted hazard ratio [95% confidence interval] 0.84 [0.77–0.90], p19 mm for women and >16 mm for men, enabling discrimination between low- and high-risk patients. Mortality was 10.2% versus 0.9% in women (≤19 vs. >19 mm, p16 mm, p=0.001). In women, TAPSE >19 mm identified a subgroup with very low in-hospital mortality (1.4%) and an excellent negative predictive value (98.6%). Conclusion: In patients with acute PE, TAPSE measured at admission in women, but not in men, was the only echocardiographic parameter independently associated with all-cause in-hospital mortality.

1 September 2023 in Experimental and Applied Biomedical Research (EABR)
Verified
Journal Article
Open access
LJLjiljana Jovanovic
Ljiljana Jovanovic
VSVesna Subota
Vesna Subota
MRMilena Rajkovic
Milena Rajkovic
BSBojana Subotic
Bojana Subotic
BDBoris Dzudovic
Boris Dzudovic
SOSlobodan Obradovic
Slobodan Obradovic
Sciendo provides publishing services and solutions to academic and professional organizations and individual authors. We publish journals, books, conference proceedings and a variety of other publications.

1 January 2023 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
NĆNeda Ćićarić
Neda Ćićarić
DSDjordje Stevanovic
Djordje Stevanovic
DNDusan Nikolic
Dusan Nikolic
VMVladimir Miloradovic
Vladimir Miloradovic
Introduction. Coronary artery spasm (CAS) is defined as a transient vasoconstriction of an epicardial coronary artery with a total or subtotal vessel occlusion, causing myocardial ischemia. Although the overall incidence of CAS during coronary angiography is estimated to be between 0.3% and 1%, CAS remains an underdiagnosed and undertreated cause of acute cardiac events. Case outline. In this article, we report a case of a 62-year-old male presenting with cardiac arrest and repeated ST-segment elevations during chest pain episodes, caused by initially unrecognized CAS. Although percutaneous coronary intervention (PCI) is generally not recommended for the treatment of CAS, due to clinical manifestations and the presence of underlying flow-limiting stenosis, we decided to perform PCI of the left anterior descending coronary artery. During the two-year-follow up period, the patient reported no chest pains nor exercise limitations at regular outpatient controls. Conclusion. Coronary artery spasms should be considered an unrecognized cause of refractory angina, acute coronary syndrome, malignant arrhythmia, and even cardiac arrest. Although medical therapy is the first option for CAS treatment, PCI could be a safe and effective approach in selected patients.